Women of Color in Pharma Marks Official Launch with First Annual Conference

facebooktwittergoogle_plusredditpinterestlinkedinmail

Women of Color in Pharma (WOCIP)  announced that its official launch took place at the WOCIP first annual conference in Princeton, N.J. WOCIP is a professional society focused on fostering the growth and development of Black and Latina women in the pharmaceutical industry. WOCIP enables the cultivation of a sustainable pipeline of Black and Latina women leaders who, together, can harness the power of their diverse expertise, bringing a competitive advantage to industry.

“WOCIP’s vision is to enable the transformation of the pharmaceutical professional landscape with women of color,” said co-founder Charlotte Jones-Burton, M.D., M.S. “Our mission is to empower women of color in pharma to excel in their personal and professional development and to transform their pathway within the pharmaceutical industry.”

Speakers at the first annual conference include representatives from pharmaceutical companies and contract research organizations. Wanda Bryant Hope, Chief Diversity Officer for Johnson & Johnson, will deliver the keynote address. Other speakers include Michelle Amador of Covance, Marisa Co of Bristol-Myers Squibb, Cristina Santos of Sanofi, and Celeste Warren of Merck. The conference is co-sponsored by Bristol-Myers Squibb and Novo Nordisk, with generous support from Covance.

“The conference theme wa s ‘Get Inspired. Be Empowered,'” said co-founder Patricia Cornet, M.A. “We welcome colleagues in the pharmaceutical industry who are interested in engaging in professional development, networking and discussing key areas that are shaping the pharmaceutical landscape for WOCIP to join us.”